Recent Comments

Psychologists Study Zero-Gravity Effects on the Human Brain (1)
computer user 14 wrote: So your doing this experiment to see if zero-g hel… [More]
Insertion of tiny heart pump without surgery (1)
Md. Saif Uddin wrote: My father is aged 57 and has TVD (Tripple Vessel D… [More]
Saffron could stop blindness and cure eye disease (2)
Marilyn wrote: Do you know where I could find this article in Fre… [More]
Department of Health announces adult autism strategy (1)
Cindy Wigglesworth wrote: My 18 year old son has Asperger's, ADHD, and anger… [More]
Concerns raised over safety of 'electronic cigarettes' (7)
carlo wrote: I had a little sore throat too. I think it was bec… [More]
Skin specialists issue warning about tan jab (1)
Melanotan wrote: Because of the side effects that they found out in… [More]

<< Sexual fantasies and anxiety related to sexual desire | New hand held computer link to emergency medical data >>

Actavis launches Ondansetron tablets in the U.S.

28. June 2007 05:17

Actavis Group has announced that it has launched Ondansetron Tablets in the U.S. Actavis will market the product under an agreement with Natco Pharma Limited. Distribution of the product will commence immediately.

Ondansetron hydrochloride tablets, the generic equivalent of GlaxoSmithKline's Zofran(R) tablets, will be available in 4 mg and 8 mg strengths. Ondansetron hydrochloride tablets are indicated for prevention of nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery.

Annual sales of Ondansetron hydrochloride tablets in the U.S. were approximately US$746 million for the twelve months ending March 2007 according to IMS Health data.

http://www.actavis.com/

17daa90c-2381-41c3-aa18-f9fc1fcdb314|0|.0

Posted in: Pharmaceutical News

Tags: Cancer, Chemotherapy, Generic Drug, Nausea, Radiation Therapy, Vomiting, Zofran

Santarus and Norgine enter into a licensing agreement for ZEGERID productsSantarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharma...Government handout of samples of potassium iodide helps to boost sales for Nukepills.comThe recent localized government handout of samples of potassium iodide has sky-rocketed sales for on...Ondansetron helps reduce vomiting, hospital admissions in children with gastroenteritisUniversity of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondanse...Pancreatitis link to Gardasil to be investigated by the TGASome Australian doctors are suggesting that a review of the cervical cancer vaccine Gardasil is call...FDA approves doripenem injection to treat complicated urinary tract and intra-abdominal infectionsThe U.S. Food and Drug Administration has approved doripenem injection, 500 mg intravenous infusion,...Antiperspirant-induced breast cancerA new study has identified a regionally-specific distribution of aluminium in breast tissue which ma...Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patientsVirginia Commonwealth University researchers have identified multiple changes in the gene-expression...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Actavis launches Ondansetron tablets in the U.S.

Actavis Group has announced that it has launched Ondansetron Tablets in the U.S. Actavis will market the product under an agreement with Natco Pharma Limited. Distribution of the product will commence immediately.

Recent Articles

Free!

Recent Comments

Twitter

Information

Actavis launches Ondansetron tablets in the U.S.

Actavis Group has announced that it has launched Ondansetron Tablets in the U.S. Actavis will market the product under an agreement with Natco Pharma Limited. Distribution of the product will commence immediately.

Medical News Cloud

Recent Articles